Cargando…

Loss of Proteostatic Control as a Substrate for Atrial Fibrillation: A Novel Target for Upstream Therapy by Heat Shock Proteins

Atrial fibrillation (AF) is the most common, sustained clinical tachyarrhythmia associated with significant morbidity and mortality. AF is a persistent condition with progressive structural remodeling of the atrial cardiomyocytes due to the AF itself, resulting in cellular changes commonly observed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meijering, Roelien A. M., Zhang, Deli, Hoogstra-Berends, Femke, Henning, Robert H., Brundel, Bianca J. J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2012
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284689/ https://www.ncbi.nlm.nih.gov/pubmed/22375124 http://dx.doi.org/10.3389/fphys.2012.00036

Ejemplares similares

Endoplasmic Reticulum Stress Is Associated With Autophagy and Cardiomyocyte Remodeling in Experimental and Human Atrial Fibrillation
por: Wiersma, Marit, et al.
Publicado: (2017)

RhoA Activation Sensitizes Cells to Proteotoxic Stimuli by Abrogating the HSF1-Dependent Heat Shock Response
por: Meijering, Roelien A. M., et al.
Publicado: (2015)

HSPB1, HSPB6, HSPB7 and HSPB8 Protect against RhoA GTPase-Induced Remodeling in Tachypaced Atrial Myocytes
por: Ke, Lei, et al.
Publicado: (2011)

Screening of novel HSP-inducing compounds to conserve cardiomyocyte function in experimental atrial fibrillation
por: van Marion, Denise MS, et al.
Publicado: (2019)

The protective role of small heat shock proteins in cardiac diseases: key role in atrial fibrillation
por: Hu, Xu, et al.
Publicado: (2017)

Cardioprotective Role of Heat Shock Proteins in Atrial Fibrillation: From Mechanism of Action to Therapeutic and Diagnostic Target
por: van Wijk, Stan W., et al.
Publicado: (2021)

Arrhythmogenic Substrates for Atrial Fibrillation in Obesity
por: Lubbers, Ellen R., et al.
Publicado: (2018)

Daily Supplementation of L-Glutamine in Atrial Fibrillation Patients: The Effect on Heat Shock Proteins and Metabolites
por: Starreveld, Roeliene, et al.
Publicado: (2020)

Evaluating Serum Heat Shock Protein Levels as Novel Biomarkers for Atrial Fibrillation
por: van Marion, Denise M. S., et al.
Publicado: (2020)

DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD(+) depletion in experimental atrial fibrillation
por: Zhang, Deli, et al.
Publicado: (2019)

The future of atrial fibrillation therapy: intervention on heat shock proteins influencing electropathology is the next in line
por: Lanters, E.A.H., et al.
Publicado: (2015)

Rapid Atrial Pacing Promotes Atrial Fibrillation Substrate in Unanesthetized Instrumented Rats
por: Mulla, Wesam, et al.
Publicado: (2019)

In silico Comparison of Left Atrial Ablation Techniques That Target the Anatomical, Structural, and Electrical Substrates of Atrial Fibrillation
por: Roney, Caroline H., et al.
Publicado: (2020)

Comparison of Unipolar and Bipolar Voltage Mapping for Localization of Left Atrial Arrhythmogenic Substrate in Patients With Atrial Fibrillation
por: Nairn, Deborah, et al.
Publicado: (2020)

Targeting the Substrate in Ablation of Persistent Atrial Fibrillation: Recent Lessons and Future Directions
por: Stiles, Martin K., et al.
Publicado: (2018)

A Computational Study of the Electrophysiological Substrate in Patients Suffering From Atrial Fibrillation
por: Pagani, S., et al.
Publicado: (2021)

Mitochondrial Dysfunction Underlies Cardiomyocyte Remodeling in Experimental and Clinical Atrial Fibrillation
por: Wiersma, Marit, et al.
Publicado: (2019)

Editorial: Innovative Approaches to Tackle Atrial Fibrillation: From Bench to Bedside
por: Ai, Xun, et al.
Publicado: (2020)

DNA Damage, an Innocent Bystander in Atrial Fibrillation and Other Cardiovascular Diseases?
por: Ramos, Kennedy S., et al.
Publicado: (2020)

Prevention of Atrial Fibrillation: Putting Proteostasis Derailment Back on Track
por: Kishore, Preetam, et al.
Publicado: (2023)

Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation
por: Bayer, Jason D., et al.
Publicado: (2019)

The Genetic Puzzle of Familial Atrial Fibrillation
por: Ragab, Ahmed A. Y., et al.
Publicado: (2020)

Nitric Oxide Synthases and Atrial Fibrillation
por: Bonilla, Ingrid M., et al.
Publicado: (2012)

Atrial fibrillation and microRNAs
por: Santulli, Gaetano, et al.
Publicado: (2014)

Cerebrovascular Dysfunction in Atrial Fibrillation
por: Junejo, Rehan T., et al.
Publicado: (2020)

Immune remodeling and atrial fibrillation
por: Yao, Yajun, et al.
Publicado: (2022)

Risk of New-Onset Atrial Fibrillation Post-cavotricuspid Isthmus Ablation in Typical Atrial Flutter Without History of Atrial Fibrillation
por: Li, Jia-hui, et al.
Publicado: (2021)

Disruption of Sarcoplasmic Reticulum‐Mitochondrial Contacts Underlies Contractile Dysfunction in Experimental and Human Atrial Fibrillation: A Key Role of Mitofusin 2
por: Li, Jin, et al.
Publicado: (2022)

Regional and temporal progression of atrial remodeling in angiotensin II mediated atrial fibrillation
por: Jansen, Hailey J., et al.
Publicado: (2022)

An Introduction to Murine Models of Atrial Fibrillation
por: Riley, Genna, et al.
Publicado: (2012)

Role of Inflammation in the Pathogenesis of Atrial Fibrillation
por: Ihara, Kensuke, et al.
Publicado: (2022)

The Fibrotic Substrate in Persistent Atrial Fibrillation Patients: Comparison Between Predictions From Computational Modeling and Measurements From Focal Impulse and Rotor Mapping
por: Boyle, Patrick M., et al.
Publicado: (2018)

Dissecting the Molecular Mechanisms Driving Electropathology in Atrial Fibrillation: Deployment of RNA Sequencing and Transcriptomic Analyses
por: Huiskes, Fabries G., et al.
Publicado: (2023)

Cell-Free Circulating Mitochondrial DNA: A Potential Blood-Based Marker for Atrial Fibrillation
por: Wiersma, Marit, et al.
Publicado: (2020)

Upstream Therapy for Atrial Fibrillation Prevention: The Role of Sacubitril/Valsartan
por: De Vecchis, Renato, et al.
Publicado: (2020)

The application and mechanism of Chinese medicine in the upstream treatment of atrial fibrillation
por: Liu, Min, et al.
Publicado: (2023)

Proteomic Analysis of Atrial Appendages Revealed the Pathophysiological Changes of Atrial Fibrillation
por: Liu, Ban, et al.
Publicado: (2020)

Inhibition of Adenosine Pathway Alters Atrial Electrophysiology and Prevents Atrial Fibrillation
por: Soattin, Luca, et al.
Publicado: (2020)

Linking Electrical Drivers With Atrial Cardiomyopathy for the Targeted Treatment of Atrial Fibrillation
por: Ho, Gordon, et al.
Publicado: (2020)

Premature atrial contractions: A predictor of atrial fibrillation and a relevant marker of atrial cardiomyopathy
por: Guichard, Jean-Baptiste, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3dujbt189rruqtk2j3p44kosd1